Empagliflozin Market Insights, Size and Growth Forecast To 2023

Published: Feb 2019	Report ID: PHAR1902	Pages: 1 - 91	Formats^*:
Category : Pharmaceutical

Report description

The market research report of Empagliflozin includes all integrated approach to growth of the market along with an elaborate & accurate analysis of the complete competitive situation of this market on a global level with the key market trends & newest technologies, being a major part in the growth during the estimated period. Besides the current analytical & statistical account, the report cloaks the trends market drivers, challenges, potential opportunities, which have an effect on the market. This market report discusses the present situation to predicted trends & aspects of the Empagliflozin market. Furthermore, it gives a dynamic overview & insights related to the market at both global as well as regional scale. Empagliflozin patent will expire in 2024 & become generic in the market, presently (2017-18) Empagliflozin share market size of 5.44 Million USD for the session (2014-18). The Empagliflozin market will expected to grow from 5.44 Million USD to 29.74 Million USD with a CAGR of 23.8% for the session (2018-23), the key reason of growth is upcoming patent expiry & increasing no. of DMF filed manufacturer.

Empagliflozin is a highly selective, potent sodium glucose cotransporter2 (SGLT2) inhibitor which work by inhibiting glucose reabsorption in the kidney, empagliflozin enhance the urinary excretion of glucose and leads to reduces plasma glucose levels, it is an effective and generally well tolerated antihyperglycaemic agent approved for the treatment of adults with type 2 diabetes (T2D) in the EU, USA and Japan, among other country of the world. As with various members of its class, empagliflozin offers the convenience of oncedaily oral administration and carries a low inherent risk of hypoglycaemia result of which its insulinindependent mechanism of action, enabling it to be used as monotherapy and as a component of combination therapy with other antidiabetic agents with complementary modes of action to improve glycaemic control in patients with T2D.

This report represents the global and regional analysis of "Empagliflozin" in terms of Dosage, Strength, API, application wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent wise (North America, Europe, Asia, South America, Africa & Oceania) manufacturer & consumer analysis & market share.

REPORT HIGHLIGHTS

Provide manufacturing capacity, consumption, current & past status & also the forecasting up to 2023.
Provide complete overview including type, application & forecast region.
Provide complete analysis of API & formulation including brand names, strength & market overview.
Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
Historical, current and projected market size in terms of volume and value.
Analyze the global & regional potential market, advantages, risk & opportunity.
Identify significant trends and factors driving or inhibiting market growth.
In-depth coverage of the complete market in terms of supplier, buyer, price, trend, growth & forecasting.

THE REPORT COVERS EXHAUSTIVE ANALYSIS ON

Market Segments
Market Dynamics
Brands in Market
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Forecasting
Technology

THE REPORT INCLUDES REGIONAL ANALYSIS ON

Asia Pacific (China, India, South Korea, Hong Kong & Rest of Asia Pacific Available)
Europe (Germany, Switzerland, France, United Kingdom & Rest of Europe Available
North America (Canada, El Salvador, United States & Rest of North America Available)
South America (Argentina)
Middle East & Africa (Egypt)

TOP PLAYERS IN EMPAGLIFLOZIN INDUSTRY

ZhejiangHuayi Pharmaceutical CoLtd
Teva API India Pvt Ltd
Wuhan Fortuna Chemical Co., Ltd.
***********************
Zhejiang Zetian Fine Chemicals Co. Ltd
Mylan Laboratories Ltd
***********************
Morepen Laboratories Ltd
***********************
***********************

KEY QUESTIONS ANSWERED BY REPORT

What was the market size trend of 2014-2017?
What will be the market size trend of the next 45 years?
What are the most common brands in terms of volume?
How many brands available for Empagliflozin?
Who are the key players of Empagliflozin API?
What are the major application industries & emerging industries?
Who are the key vendors present in the market?
How future opportunities & market drivers will affect market dynamics & on-going trends?
Which one segment from global coverage will be lucrative & will grow?
What are the main market opportunities and threats faced by the vendors?
What are the strategies are following by the existing market players?

CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 EMPAGLIFLOZIN EXECUTIVE SUMMARY

CHAPTER 4 EMPAGLIFLOZIN BASIC HIGHLIGHTS

4.1. Empagliflozin Overview
4.2. Empagliflozin CAS No
4.3. Empagliflozin Molecular Weight
4.4. Empagliflozin Molecular Formula
4.5. Empagliflozin Originator
4.6. Empagliflozin Developer
4.7. Empagliflozin Priority Date
4.8. Empagliflozin Patent Expiry

CHAPTER 5 GLOBAL EMPAGLIFLOZIN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Empagliflozin Forms & Grade Description
5.2. Empagliflozin Synonym
5.3. Empagliflozin Indication
5.4. Empagliflozin Route of Administration & Dosage

CHAPTER 6 EMPAGLIFLOZIN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Raw Material Required For Empagliflozin Manufacturing Process
6.2. Empagliflozin Manufacturing Process & Flow Diagram
6.3. Empagliflozin Chemical Reaction

CHAPTER 7 EMPAGLIFLOZIN BRAND LIST & MECHANISM OF ACTION

7.1. Empagliflozin Brand List & Dosage with Strength
7.2. Empagliflozin Mechanism of Action

CHAPTER 8 EMPAGLIFLOZIN REGION WISE MARKET OVERVIEW

8.1. Empagliflozin Market Overview In Asia-Pacific (China, India, South Korea, Hong Kong & Rest of Asia Pacific Available)
8.2. Empagliflozin Market Overview In Europe (Germany, Switzerland, France, United Kingdom & Rest of Europe Available
8.3. Empagliflozin Market Overview In North America (Canada, El Salvador, United States & Rest of North America Available)
8.4. Empagliflozin Market Overview In South America South America (Argentina)
8.5. Empagliflozin Market Overview In Middle East & Africa (Egypt & Rest of MEA Available)

CHAPTER 9 EMPAGLIFLOZIN CONTINENT & COUNTRY WISE COMPETITIVE LANDSCAPE ANALYSIS

9.1. Empagliflozin Global Manufacturer Overview
9.2. Empagliflozin Continent Wise Production Volume Analysis
9.3. Empagliflozin Country Wise Production Volume
9.4. Empagliflozin Top Player Analysis
9.5. Empagliflozin Continent Wise Market Share
9.6. Empagliflozin Manufacturers Deliverable Format

CHAPTER 10 EMPAGLIFLOZIN GLOBAL PRICE TREND ANALYSIS OF LAST 5 YEARS (2014-2018)

10.1. Empagliflozin Continent & Country Wise 2014 Price Range Analysis
10.2. Empagliflozin Continent & Country Wise 2015 Price Range Analysis
10.3. Empagliflozin Continent & Country Wise 2016 Price Range Analysis
10.4. Empagliflozin Continent & Country Wise 2017 Price Range Analysis
10.5. Empagliflozin Continent & Country Wise 2018 Price Range Analysis

CHAPTER 11 EMPAGLIFLOZIN GLOBAL MARKET OVERVIEW

11.1. Global Demand/ Supply & Prices Analysis
11.2. Key Players Involved (Capacities & Prices)

CHAPTER 12 EMPAGLIFLOZIN GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2018-2023) ANALYSIS

12.1. Empagliflozin Global Market Size & Market Growth In Terms of Volume (2014-17)
12.2. Empagliflozin Global Market Size & Market Growth In Terms of Value Million USD (2014-17)
12.3. Empagliflozin Global Market Size & Market Growth In Terms of Volume (2018-23)
12.4. Empagliflozin Global Market Size & Market Growth In Terms of Value Million USD (2018-23)

CHAPTER 13 EMPAGLIFLOZIN CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

13.1. Empagliflozin Global Consumer Overview
13.2. Empagliflozin Continent Wise Consumption Analysis
13.3. Empagliflozin Key Consumers
13.4. Empagliflozin Continent Wise Market Share
13.5. Empagliflozin List of Countries Involved in Consumption
13.6. Empagliflozin Consumer Deliverable Format

CHAPTER 14 EMPAGLIFLOZIN REGULATORY INSIGHTS

14.1. Empagliflozin List of Patent Filed
14.2. Empagliflozin DMF Holders
14.3. Empagliflozin SPC Filed
14.4. Empagliflozin Trial
14.5. Empagliflozin US DMF Filed
14.6. Empagliflozin HS Code Wise Indian Custom Import Duty

CHAPTER 15 EMPAGLIFLOZIN CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Global Empagliflozin Export Analysis (2017-18)
15.2. Global Empagliflozin Import Analysis (2017-18)
15.3. Global Empagliflozin Export-Import Analysis (2014-18)
15.4. Global Empagliflozin Continent Wise Export Analysis (2014-18)
15.5. Global Empagliflozin Continent Wise Import Analysis (2014-18)
15.6. Global Empagliflozin Country Wise Import Analysis (2014-18)
15.7. Global Empagliflozin Country Wise Export Analysis (2014-18)
15.8. Global Empagliflozin Importer Wise Import Analysis (2014-18)
15.9. Global Empagliflozin Exporter Wise Export Analysis (2014-18)

CHAPTER 16 EMPAGLIFLOZIN WORLDWIDE SWOT ANALYSIS

16.1. Empagliflozin Strength Analysis
16.2. Empagliflozin Weakness Analysis
16.3. Empagliflozin Opportunity Analysis
16.4. Empagliflozin Threat Analysis

CHAPTER 17 EMPAGLIFLOZIN REPORT BASED BUSINESS RECOMMENDATION

LIST OF TABLES

Table 1 : List of Manufacturing Equipment Required
Table 2 : Raw Material Required for 1 KG Empagliflozin Manufacturing
Table 3 : List of Global Brand With Strength & Dosage Type
Table 4 : Empagliflozin Country Wise Asian Market Overview
Table 5 : Empagliflozin Country Wise European Market Overview
Table 6 : Empagliflozin Country Wise North American Market Overview
Table 7 : Empagliflozin Country Wise South American Market Overview
Table 8 : Empagliflozin Country Wise African Market Overview
Table 9 : Empagliflozin Continent Wise Global Manufacturer Market Overview
Table 10 : Empagliflozin Manufacturer Deliverable Format
Table 11 : Empagliflozin Continent & Country Wise 2014 Price Range Analysis
Table 12 : Empagliflozin Continent & Country Wise 2015 Price Range Analysis
Table 13 : Empagliflozin Continent & Country Wise 2016 Price Range Analysis
Table 14 : Empagliflozin Continent & Country Wise 2017 Price Range Analysis
Table 15 : Empagliflozin Continent & Country Wise 2018 Price Range Analysis
Table 16 : List of Key Manufacturer With Approximate Price
Table 17 : Market Size in Terms of Volume (KG) Analysis (2014-17)
Table 18 : Market Size in Terms of Million USD Analysis (2014-17)
Table 19 : Market Size in Terms of Volume (KG) Analysis (2018-23)
Table 20 : Market Size in Terms of Volume Million USD Analysis (2018-23)
Table 21 : Global Empagliflozin Consumer Analysis
Table 22 : Global Empagliflozin Consumer Deliverable Format
Table 23 : Empagliflozin Patent Overview & Format
Table 24 : Empagliflozin DMF Filed
Table 25 : Empagliflozin SPC Filed
Table 26 : Empagliflozin Trial List
Table 27 : Empagliflozin List of US DMF Filed
Table 28 : Empagliflozin Indian Custom Import Duty For HS Code 29420090
Table 29 : Empagliflozin Indian Custom Import Duty For HS Code 30049099
Table 30 : Empagliflozin Indian Custom Import Duty For HS Code 30041090
Table 31 : Global Empagliflozin Export Analysis (2017-18)
Table 32 : Global Empagliflozin Import Analysis (2017-18)
Table 33 : Global Empagliflozin Export-Import Analysis (2014-18)
Table 34 : Global Empagliflozin Continent Wise Export Analysis (2014-18)
Table 35 : Global Empagliflozin Continent Wise API Import Analysis (2014-18)
Table 36 : Global Empagliflozin Country Wise API Import Analysis (2014-18)
Table 37 : Global Empagliflozin Country Wise API Export Analysis (2014-18)
Table 38 : Global Empagliflozin Importer Wise Import Analysis (2014-18)
Table 39 : Global Empagliflozin Exporter Wise Export Analysis (2014-18)

LIST OF FIGURES

Figure 1 : Continent Wise Market Share Analysis
Figure 2 : Empagliflozin Structure
Figure 3 : Empagliflozin Dosage Type
Figure 4 : Empagliflozin Stage 1 Flow Chart
Figure 5 : Empagliflozin Stage 2 Flow Chart
Figure 6 : Empagliflozin Stage 3 Flow Chart
Figure 7 : Empagliflozin Stage 4 Flow Chart
Figure 8 : Empagliflozin Chemical Reaction
Figure 9 : Empagliflozin Mechanism of Action
Figure 10 : Empagliflozin Asian Country Wise Market Overview
Figure 11 : Empagliflozin Country Wise European Market Overview
Figure 12 : Empagliflozin Country Wise North American Market Overview
Figure 13 : Empagliflozin Continent Wise Global Manufacturer
Figure 14 : Empagliflozin Continent Wise Manufacturer Production Volume
Figure 15 : Empagliflozin Country Wise Manufacturer Production Volume
Figure 16 : Empagliflozin Key Players
Figure 17 : Continent Wise API Market Share Analysis
Figure 18 : Global Demand Supply Overview Analysis
Figure 19 : Global Continent Wise Empagliflozin No. of Consumers
Figure 20 : Global Continent Wise Empagliflozin Consumption Volume
Figure 21 : Global Continent Wise Empagliflozin Key Consumer Analysis
Figure 22 : Global Continent Wise Consumer Market Share Overview
Figure 23 : Global Country Wise Consumer Market Share Overview
Figure 24 : Global Continent Wise API Export Overview
Figure 25 : Global Continent Wise API Import Overview
Figure 26 : Global Continent Wise API Export Import (2014-2018) Overview

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1